By Femtech Insider Breast Health, Cancer, News, Pharma, Research 11 hours ago ShareTwitterFacebookPinterest-circled FDA Approves Celcuity’s REVTORPYK for HR+/HER2-, PIK3CA Wild-Type Advanced Breast Cancer
By Femtech Insider Breast Health, Cancer, News, Pharma 3 days ago ShareTwitterFacebookPinterest-circled Roche’s Genentech Signs $490M Breast Cancer Drug Discovery Deal with Astex Pharmaceuticals
By Femtech Insider Breast Health, Cancer, Investment, News July 10, 2026 ShareTwitterFacebookPinterest-circled Imagion Biosystems Raises AU$3.75M; Extends Siemens Partnership to Advance Breast Cancer Trial
By Femtech Insider Breast Health, Cancer, News July 7, 2026 ShareTwitterFacebookPinterest-circled FDA Approves Pfizer’s IBRANCE for HR+/HER2+ Metastatic Breast Cancer
By Femtech Insider Breast Health, Cancer, News July 2, 2026 ShareTwitterFacebookPinterest-circled Quibim Launches AI Tool for Breast Cancer Detection via MRI in Europe and the UK
By Femtech Insider Breast Health, Cancer, News, Regulatory June 24, 2026 ShareTwitterFacebookPinterest-circled Spotlight Medical Secures CE Mark for AI Breast Cancer Prognostic Test
By Femtech Insider Breast Health, Investment, News June 10, 2026 ShareTwitterFacebookPinterest-circled Mammogen Raises Up to $30M for RNA Blood Test That Could Reduce Unnecessary Breast Biopsies
By Femtech Insider Breast Health, Cancer, News, Research June 1, 2026 ShareTwitterFacebookPinterest-circled OPTIMA Trial Finds Gene Test Can Identify Breast Cancer Patients Who Can Safely Forgo Chemotherapy
